Serina Therapeutics Statistics

Total Valuation

SER has a market cap or net worth of $45.90 million. The enterprise value is $54.38 million.

Market Cap	45.90M
Enterprise Value	54.38M

Important Dates

The last earnings date was Tuesday, November 12, 2024, after market close.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

SER has 9.89 million shares outstanding. The number of shares has decreased by -7.43% in one year.

Current Share Class	9.89M
Shares Outstanding	9.89M
Shares Change (YoY)	-7.43%
Shares Change (QoQ)	+5.85%
Owned by Insiders (%)	27.65%
Owned by Institutions (%)	5.56%
Float	2.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.43
Forward PS	n/a
PB Ratio	-3.32
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	17.22
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.40

Current Ratio	0.40
Quick Ratio	0.24
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-16.43

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-86.73%
Return on Invested Capital (ROIC)	-257.92%
Return on Capital Employed (ROCE)	185.17%
Revenue Per Employee	$287,045
Profits Per Employee	-$668,104
Employee Count	11
Asset Turnover	0.39
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -65.81% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-65.81%
50-Day Moving Average	4.79
200-Day Moving Average	6.78
Relative Strength Index (RSI)	45.47
Average Volume (20 Days)	9,189

Short Selling Information

The latest short interest is 34,152, so 0.35% of the outstanding shares have been sold short.

Short Interest	34,152
Short Previous Month	31,850
Short % of Shares Out	0.35%
Short % of Float	1.15%
Short Ratio (days to cover)	1.97

Income Statement

In the last 12 months, SER had revenue of $3.16 million and -$7.35 million in losses. Loss per share was -$1.28.

Revenue	3.16M
Gross Profit	-2.86M
Operating Income	-11.26M
Pretax Income	-890,146
Net Income	-7.35M
EBITDA	-11.11M
EBIT	-11.26M
Loss Per Share	-$1.28

Full Income Statement

Balance Sheet

The company has $3.19 million in cash and $11.67 million in debt, giving a net cash position of -$8.48 million or -$0.86 per share.

Cash & Cash Equivalents	3.19M
Total Debt	11.67M
Net Cash	-8.48M
Net Cash Per Share	-$0.86
Equity (Book Value)	-13.83M
Book Value Per Share	-1.55
Working Capital	-8.09M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$12.43 million and capital expenditures -$87,015, giving a free cash flow of -$12.52 million.

Operating Cash Flow	-12.43M
Capital Expenditures	-87,015
Free Cash Flow	-12.52M
FCF Per Share	-$1.27

Full Cash Flow Statement

Margins

Gross margin is -90.70%, with operating and profit margins of -356.51% and -232.75%.

Gross Margin	-90.70%
Operating Margin	-356.51%
Pretax Margin	-234.46%
Profit Margin	-232.75%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SER does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	7.43%
Shareholder Yield	7.43%
Earnings Yield	-16.01%
FCF Yield	-27.27%

Analyst Forecast

The average price target for SER is $11.00, which is 137.07% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$11.00
Price Target Difference	137.07%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SER has an Altman Z-Score of -7.8 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-7.8
Piotroski F-Score	2